Our FDA-approved FemiLift laser procedure helps women revitalize sensitive feminine tissue. After FemiLift, women feel tighter, more lubricated and report increased intimate satisfaction. It helps with mild stress incontinence too. And their partners can feel the difference as well.
Over 50% of women have dryness after menopause. In addition, a number also report pain during sexual intercourse.
50% of new moms report urinary leakage. 20% report increased looseness that wasn't there before giving birth.
70% of breast cancer survivors experience vaginal dryness, pain during sex, and irritation. This atrophic vaginitis can also include itching, burning, vaginal discharge, and soreness.
The FemiLift is an FDA-approved laser technology developed by Alma Lasers. It is used for treatment of vaginal atrophy, looseness and dryness. In addition, women also report it improves their mild stress urinary incontinence.
This non-invasive, non-hormonal treatment provides instant vaginal rejuvenation without pain or need for anesthesia. Reassuringly, the simple out-patient procedure has delivered life-changing benefits to over 220,000 women. And their partners.
FemiLift's growing popularity is due the the remarkable results it produces. It's so effective that some patients even notice results after a single session. All have results by the end of the treatments. Most importantly, the results only improve with each treatment.
After childbirth or during menopause, vaginal tissue can overstretch, resulting in a feeling of vaginal looseness and reduced sensitivity. Naturally, this can decrease sexual sensation and satisfaction.
If you experienced this but thought it was just something “you had to live with” think again.
Nearly 28 million women in the US suffer with SUI – Stress Urinary Incontinence. That is to say, you have the involuntary leaking of urine when you sneeze, cough, laugh, jump or even lift something heavy.
How to know? You probably have SUI, if you have to cross your legs when you sneeze.
After FemiLift, the new rejuvenated cells of the vaginal wall again produce natural lubrication while also normalizing the vagina’s pH balance. The result is greater lubrication and fewer infections!
Post-Menopause hormonal changes can result in thinning vaginal walls.
This safe and gentle FDA approved treatment uses CO2 laser technology to trigger the production of collagen and elastin through the deep thermal heating of the fibroblast cells in the vaginal area. When you come in for your FemiLift vaginal rejuvenation treatment, your very private practitioner will insert a slender surgical steel wand into the opening of your vagina with a 360-degree hand piece that allows for greater accuracy and precision when targeting specific areas of the vagina.
While many patients notice results after a single session, between 3 and 4 treatments are recommended in order to enjoy the full benefits of the FemiLift treatment. You may come back for a yearly maintenance session or whenever your body tells you it’s ready to ensure that tightening and continence effects are present for a lengthened period of time; some even have indefinite results.
FemiLift is a non-invasive procedure with very few side effects. Occasionally patients my experience a watery discharge for up to 48 hours following treatment. Normal activity can be resumed immedately afterward, although it is recommended to abstain from intercourse for approximately 5 days post-treatment. You can expect to feel less urinary urgency and a greater sense of comfort right away.
Dr Fisher recommends that you abstain from intercourse for approximately 5 days post-treatment.
FemiLift costs $1800. But for a limited time, we have reduced the price to $1500! THE FIRST 5 FEMILIFT CLIENTS in March 2021 will only pay $1200 – a $600 savings!! Financing plans are available. By paying over time, your monthly payments can be as low as $100. Our clients who have had a Femilift report they have never made a better investment.
Here are two links to articles written by the National Institute of Health on vaginal atrophy after menopause, and in cancer survivors.
Get information and support.